Taiko Pharmaceutical Co.,Ltd.
4574.T
Price:
$291
Market Cap:
$14.62B
Taiko Pharmaceutical Co.,Ltd. engages in pharmaceuticals, infection control, and other businesses. The company manufactures and sells non-prescription drugs under the Seirogan and Seirogan Toi-A brands for the treatment of loose stools, diarrhea, food and water poisoning, vomiting, and related conditions; tablets for diarrhea; and quasi-drugs, such as Trumpet Intestinal Regulator BF. It also manufactures and sells sanitation control products under the Cleverin brand name to wholesalers, as well as Cleverin generator, a machine that emits low concentrations of chlorine dioxide gas; and supplies products using the patented Cleverin technology through OEM agreements and products developed joint...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2009-03-18
Stock Exchange
JPX
Ticker
4574.T
PE Ratio
[-5.86]
ROE
[5.30%]
Current Ratio
[3.07]
Dividend Yield
[0%]
Enterprise Value
[12.12B]
Dividend History
The ROE as of December 2025 (TTM) for Taiko Pharmaceutical Co.,Ltd. (4574.T) is 5.30%
According to Taiko Pharmaceutical Co.,Ltd.’s latest financial reports and current stock price. The company's current ROE is 5.30%. This represents a change of 81.82% compared to the average of 2.92% of the last 4 quarters.
Taiko Pharmaceutical Co.,Ltd. (4574.T) Historical ROE (quarterly & annually)
How has 4574.T ROE performed in the past?
The mean historical ROE of Taiko Pharmaceutical Co.,Ltd. over the last ten years is -12.05%. The current 5.30% ROE has changed -144.00% with respect to the historical average. Over the past ten years (40 quarters), 4574.T's ROE was at its highest in in the June 2020 quarter at 9.05%. The ROE was at its lowest in in the December 2021 quarter at -59.72%.
Average
-12.05%
Median
6.74%
Minimum
-74.92%
Maximum
16.91%
Taiko Pharmaceutical Co.,Ltd. (4574.T) ROE by Quarter and Year
Discovering the peaks and valleys of Taiko Pharmaceutical Co.,Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 56.43%
Maximum Annual ROE = 16.91%
Minimum Annual Increase = -543.11%
Minimum Annual ROE = -74.92%
| Year | ROE | Change |
|---|---|---|
| 2024 | 11.28% | -121.05% |
| 2023 | -53.59% | -11.93% |
| 2022 | -60.85% | -18.78% |
| 2021 | -74.92% | -543.11% |
| 2020 | 16.91% | 33.50% |
| 2020 | 12.66% | 56.43% |
| 2019 | 8.10% | 21.39% |
| 2018 | 6.67% | -2.24% |
| 2017 | 6.82% | 6.69% |
| 2016 | 6.39% | -54.96% |
Taiko Pharmaceutical Co.,Ltd. (4574.T) Average ROE
How has 4574.T ROE performed in the past?
The current ROE of Taiko Pharmaceutical Co.,Ltd. (4574.T) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-34.39%
5-year avg
-32.23%
10-year avg
-12.05%
Taiko Pharmaceutical Co.,Ltd. (4574.T) ROE vs. Peers
How is 4574.T’s ROE compared to its peers?
Taiko Pharmaceutical Co.,Ltd.’s ROE is less than Fuso Pharmaceutical Industries,Ltd. (7.01%), less than Colan Totte.Co.,Ltd. (27.83%), less than Medical System Network Co., Ltd. (7.33%), greater than Solasia Pharma K.K. (-137.19%), less than Daiken Medical Co., Ltd. (13.89%), greater than MediciNova, Inc. (-23.12%), greater than RaQualia Pharma Inc. (-9.15%), less than Hoshi Iryo-Sanki Co., Ltd. (8.34%), less than Techno Medica Co., Ltd. (6.08%), greater than CellSeed Inc. (-53.29%),
| Company | ROE | Market cap |
|---|---|---|
| 7.01% | $18.29B | |
| 27.83% | $13.15B | |
| 7.33% | $14.76B | |
| -137.19% | $8.44B | |
| 13.89% | $12.64B | |
| -23.12% | $11.53B | |
| -9.15% | $27.61B | |
| 8.34% | $15.30B | |
| 6.08% | $14.26B | |
| -53.29% | $9.36B |
Build a custom stock screener for Taiko Pharmaceutical Co.,Ltd. (4574.T) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Taiko Pharmaceutical Co.,Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Taiko Pharmaceutical Co.,Ltd. (4574.T) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Taiko Pharmaceutical Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Taiko Pharmaceutical Co.,Ltd.'s ROE?
How is the ROE calculated for Taiko Pharmaceutical Co.,Ltd. (4574.T)?
What is the highest ROE for Taiko Pharmaceutical Co.,Ltd. (4574.T)?
What is the 3-year average ROE for Taiko Pharmaceutical Co.,Ltd. (4574.T)?
What is the 5-year average ROE for Taiko Pharmaceutical Co.,Ltd. (4574.T)?
How does the current ROE for Taiko Pharmaceutical Co.,Ltd. (4574.T) compare to its historical average?